Skip to content

Sonoco Products SON Impairment Charges

Impairment Charges at other companies

Constellium logo
ConstelliumCSTM
$4M
Westlake logo
WestlakeWLK
$181.75M
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Icahn Enterprises logo
Icahn EnterprisesIEP

Other financials

Income statement

See full
Revenue$1.7B-1.9%
Gross profit$345.6M-2.3%
Operating income$127.1M+0.2%
Net income$67.6M+24.2%
EPS (diluted)$0.68+23.6%

Balance sheet

See full
Cash & equivalents$224.5M+17.1%
Total debt$6.3B-35.2%
Total equity$3.6B+45.8%
Total assets$11.1B-12.7%

Cash flow

See full
Operating cash flow-$367.9M-76.8%
CapEx$62.1M-33.0%
Free cash flow-$430.0M-43.0%

Valuation

See full
Market cap$5.01B+14.5%
Enterprise value$11.05B-19.5%
P/E4.9×-23.6×
P/S0.7×-0.1×

Profitability

See full
Gross margin20.9%-0.5pp
Operating margin13.6%+6.9pp
Net margin13.6%+10.9pp
FCF margin2.9%+1.8pp

Returns & leverage

See full
Return on equity33.8%+27.5pp
Debt / equity1.8×-2.2×
Current ratio+0.2×

Where this comes from

Reported directly by Sonoco Products in its filing.

Tagged under the XBRL concept us-gaap:AssetImpairmentCharges.

The official record: Sonoco Products’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sonoco Products's impairment charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sonoco Products's impairment charges?
Sonoco Products (SON) reported impairment charges of $3.09M in Q1 2026.
How has Sonoco Products's impairment charges changed year-over-year?
Sonoco Products's impairment charges decreased by 37.6% year-over-year, from $4.95M to $3.09M.
What does impairment charges mean?
Write-downs of long-lived assets (excluding goodwill) when their carrying value exceeds fair value, including property, equipment, right-of-use assets, and other tangible assets.